Inflammatory bowel disease management. Some thoughts on future drug developments

Drugs

Volumn 53, Issue 2, 1997, Pages 189-194

  Rhodes, John ^a   Thomas, Gareth ^a   Evans, Brian K ^b  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b South Glamorgan Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ARSENIC DERIVATIVE; AZATHIOPRINE; BISMUTH; CARBENOXOLONE; CARBOMER; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN; EUDRAGIT; FISH OIL; FLUTICASONE PROPIONATE; LIDOCAINE; LIPOXYGENASE INHIBITOR; MESALAZINE; METASULFOBENZOATE; METRONIDAZOLE; NICOTINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; SUCRALFATE; THALIDOMIDE; TIXOCORTOL PIVALATE; TOBRAMYCIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

CLINICAL PROTOCOL; CROHN DISEASE; DELAYED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RESEARCH; ENTERITIS; HUMAN; INFLAMMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOGENESIS; RECTAL DRUG ADMINISTRATION; SHORT SURVEY; ULCERATIVE COLITIS;

EID: 0031037071     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199753020-00001     Document Type: Short Survey

References (36)

1. Hanauer SB. Drug therapy: inflammatory bowel disease. N Engl J Med 1996; 334: 841-8
2. Hanauer SB. Medical therapy of ulcerative colitis. Lancet 1993; 342: 412-7
3. Cole AT, Hawkey CJ. Treatment of inflammatory bowel disease from now to the millennium. Baillieres Clin Gastroenterol 1994; 8 (2): 351-79
4. Carpani De Kaski M, Hodgson HJF. Rolling review: inflammatory bowel disease. Aliment Pharmacol Ther 1993; 7: 567-79
5. Lennard-Jones JE. Inflammatory bowel disease: medical therapy revisited. Scand J Gastroenterol 1992; 27 Suppl. 192: 110-6
6. Azad-Kahn AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977; II: 892-5
7. Chan RP, Pople DJ, Gilbert AP, et al. Studies of two novel sulphasalazine analogs ipsalazide and salsalazide. Dig Dis Sci 1983; 28: 609-15
8. Willoughby CP, Aronson JR, Agback H, et al. Distribution and metabolism in healthy volunteers of disodium azodisalyclate, a potential therapeutic agent for ulcerative colitis. Gut 1982; 23: 1081-7
9. Rasmussen SN, Bondesen S, Hvidberg EF, et al. 5-Amino-salicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans. Gastroenterology 1982; 83: 1062-70
10. Dew MJ, Hughes PH, Lee MG, et al. An oral preparation to release drugs in the human colon. Br J Clin Pharmacol 1982; 14: 405-8
11. Swill GL, Mills CM, Rhodes J, et al. A pharmacokinetic study of sulphasalazine and two new formulations of mesalazine. Aliment Pharmacol Ther 1992; 6: 259-66
12. Djimbo M, Moes AJ. Release of drugs formulated as hard pastes filled into hard gelatin capsules. J Pharm Belg 1984; 39: 36-42
13. Punchard NA, Greenfield SM, Thompson RPH. Mechanism of action of 5-aminosalicylic acid. Medial Inflamm 1992; 1: 151-65
14. Williams JG, Hallet MB. The reaction of 5-amino salicylic acid with hypochlorite. Biochem Pharmacol 1989; 38: 149-54
15. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994; 331: 836-41
16. Rutgeerts P, Loftberg R, Malchow H, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994; 331: 842-5
17. Greenberg GR, Feagan BG, Martin F, et al. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Gastroenterology 1996; 110: 45-51
18. Lee D, Taylor M, James VHT, et al. Rectally administered prednisolone - evidence for a predominantly local action. Gut 1980; 21: 215-8
19. Hanauer S, Kirsner J, Barrett W. Treatment of left-sided ulcerative colitis with tixocortol pivalate (TP) [abstract]. Gastroenterology 1986; 90: 1449
20. Wright JP, Jarnum S, Schaffalitzky de Muckadell O, et al. Oral fluticasone propionate compared with prednisolone in treatment of active Crohn's disease: a randomised double-blind multicentre study. Eur J Gastroenterol Hepatol 1993; 5: 499-503
21. Rhodes J, Pugh S, Thomas GAO. Have topical steroids a future in Crohn's disease? Eur J Gastroenterol Hepatol 1993; 5: 495-8
22. Belluzzi A, Brignole C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334: 1557-60
23. McCann ML. Reflorastation therapy for inflammatory bowel disease, both Crohn's and ulcerative colitis [abstract]. J Allergy Clin Immunol 1993; 91: 230
24. Roffe C. Biotherapy for antibioitic-associated and other diarrhoeas. J Infect 1996; 32: 1-10
25. Bjorck S, Dahlostron A, Johannson L, et al. Treatment of the mucosa with local anaesthetics in ulcerative colitis. Agents Actions 1992; Conference Issue: C60-72
26. Pullan RD, Ganesh S, Muni V, et al. Comparison of bismuth-citrate and 5-amino salicylic acid enemas in distal ulcerative colitis: a controlled trial. Gut 1943; 34: 676-9
27. Pullan RD, Thomas GAO, Rhodes M, et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 1994; 35: 353-9
28. Bell CJ, Wallace JL. Inflammatory bowel disorders: current and future drugs that modulate adhesion molecules. BioDrugs. In press
29. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. BMJ 1982; 284: 706
30. Rhodes J, Thomas GAO. Nicotine treatment in ulcerative colitis; current status. Drugs 1995; 49: 157-60
31. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330: 811-5
32. Thomas GAO, Rhodes J, Mani V, et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995; 332: 988-92
33. Thomas GAO, Rhodes J, Ragunath K, et al. Transdermnal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Eur J Gastroenterol Hepatol 1996; 8: 769-76
34. Osborne MJ, Stansby GP. Cigarette smoking and its relationship to inflammatory bowel disease: a review. J R Soc Med 1992; 85: 214-6
35. Rhodes J. New thoughts on the pathogenesis and treatment of ulcerative colitis: slate of the art lecture. In: Proceedings of the First United European Gastroenterology week, 1992 Sep 25-30; Athens: 111-9
36. Rhodes J, Thomas GAO. Smoking: good or bad for inflammatory bowel disease. Gastroenterology 1994; 106: 807-10